Identification of Non-coding RNAs and Their Functional Network Associated with Optic Nerve Invasion in Retinoblastoma

Overview

Journal Heliyon

Specialty Social Sciences

Date 2023 Feb 28

PMID 36852072

Authors

Jie Sun

Lu Gan

Jie Ding

Ruiqi Ma

Jiang Qian

Kang Xue

Affiliations

Soon will be listed here.

Abstract

Optic nerve invasion (ONI) is an important high-risk feature and prognostic indicator of retinoblastoma (RB). Emerging evidence has revealed that non-coding RNAs (ncRNAs) play important roles in tumor perineural invasion (PNI). Nevertheless, the regulatory role of ncRNAs in the ONI of RB is poorly understood. In the current study, whole-transcriptome sequencing was performed to assess the expression profiles of ncRNAs and mRNAs in RB tissues, with or without ONI. Based on Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, we predicted the biological functions of differentially expressed (DE) mRNAs. We then constructed competing endogenous RNA (ceRNA) regulatory networks based on bioinformatics analysis. The hsa_circ_0015965/lncRNA MEG3-hsa-miR-378a-5p-NOTCH1 pathway was selected and validated by real-time qPCR, western blotting, and dual luciferase reporter assays. Moreover, we demonstrated that NOTCH1 promotes the malignant progression of RB. Taken together, our results provide novel insights into the mechanism underlying optic nerve invasion in RB.

References

Piecuch A, Kucharzewski M, Kurek J, Michalski M, Jasinski D, Brzozowa-Zasada M . The clinical significance of Notch1 immunoexpression in Caucasian patients with colorectal adenocarcinoma. Prz Gastroenterol. 2021; 15(4):314-322. PMC: 7988833. DOI: 10.5114/pg.2020.101560. View

Palomero T, Lim W, Odom D, Sulis M, Real P, Margolin A . NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A. 2006; 103(48):18261-6. PMC: 1838740. DOI: 10.1073/pnas.0606108103. View

Stepulak A, Rola R, Polberg K, Ikonomidou C . Glutamate and its receptors in cancer. J Neural Transm (Vienna). 2014; 121(8):933-44. PMC: 4133641. DOI: 10.1007/s00702-014-1182-6. View

Ni H, Chai P, Yu J, Xing Y, Wang S, Fan J . LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter. Cell Death Dis. 2020; 11(5):306. PMC: 7198571. DOI: 10.1038/s41419-020-2524-y. View

Fabian I, Naeem Z, Stacey A, Chowdhury T, Duncan C, Reddy M . Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes. Am J Ophthalmol. 2017; 179:137-144. DOI: 10.1016/j.ajo.2017.05.003. View

Li A, Yang J, Zhang T, Li L, Li M . Long Noncoding RNA TRPM2-AS Promotes the Growth, Migration, and Invasion of Retinoblastoma via miR-497/WEE1 Axis. Front Pharmacol. 2021; 12:592822. PMC: 8112210. DOI: 10.3389/fphar.2021.592822. View

Chantada G, Casco F, Fandino A, Galli S, Manzitti J, Scopinaro M . Outcome of patients with retinoblastoma and postlaminar optic nerve invasion. Ophthalmology. 2007; 114(11):2083-9. DOI: 10.1016/j.ophtha.2007.01.012. View

Choucair M, Brisse H, Freneaux P, Desjardins L, Dorfmuller G, Puget S . Management of advanced uni- or bilateral retinoblastoma with macroscopic optic nerve invasion. Pediatr Blood Cancer. 2019; 67(1):e27998. DOI: 10.1002/pbc.27998. View

Ling H, Fabbri M, Calin G . MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013; 12(11):847-65. PMC: 4548803. DOI: 10.1038/nrd4140. View

10.

Wang J, Yang Y, Li K . Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9. J Cell Physiol. 2018; 233(10):6986-6995. DOI: 10.1002/jcp.26621. View

11.

Dimaras H, Corson T . Retinoblastoma, the visible CNS tumor: A review. J Neurosci Res. 2018; 97(1):29-44. PMC: 6034991. DOI: 10.1002/jnr.24213. View

12.

Liu J, Ottaviani D, Sefta M, Desbrousses C, Chapeaublanc E, Aschero R . A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nat Commun. 2021; 12(1):5578. PMC: 8458383. DOI: 10.1038/s41467-021-25792-0. View

13.

Cech T, Steitz J . The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 2014; 157(1):77-94. DOI: 10.1016/j.cell.2014.03.008. View

14.

George J, Patel T . Noncoding RNA as therapeutic targets for hepatocellular carcinoma. Semin Liver Dis. 2015; 35(1):63-74. PMC: 4427038. DOI: 10.1055/s-0034-1397350. View

15.

Munier F, Gaillard M, Balmer A, Soliman S, Podilsky G, Moulin A . Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012; 96(8):1078-83. DOI: 10.1136/bjophthalmol-2011-301450. View

16.

Kaliki S, Shields C, Cassoux N, Munier F, Chantada G, Grossniklaus H . Defining High-risk Retinoblastoma: A Multicenter Global Survey. JAMA Ophthalmol. 2021; 140(1):30-36. PMC: 8587221. DOI: 10.1001/jamaophthalmol.2021.4732. View

17.

Mauffrey P, Tchitchek N, Barroca V, Bemelmans A, Firlej V, Allory Y . Progenitors from the central nervous system drive neurogenesis in cancer. Nature. 2019; 569(7758):672-678. DOI: 10.1038/s41586-019-1219-y. View

18.

Cervantes-Villagrana R, Albores-Garcia D, Cervantes-Villagrana A, Garcia-Acevez S . Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies. Signal Transduct Target Ther. 2020; 5(1):99. PMC: 7303203. DOI: 10.1038/s41392-020-0205-z. View

19.

Li Z, Guo J, Xu X, Wang Y, Mukherji S, Xian J . Diagnosis of Postlaminar Optic Nerve Invasion in Retinoblastoma With MRI Features. J Magn Reson Imaging. 2019; 51(4):1045-1052. DOI: 10.1002/jmri.26961. View

20.

Sun J, Feng D, Xi H, Luo J, Zhou Z, Liu Q . CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy. Mol Oncol. 2020; 14(8):1740-1759. PMC: 7400807. DOI: 10.1002/1878-0261.12708. View